Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Reducing monthly expenses is key to effective debt repayment. Learn practical strategies to cut costs and manage your debt.
20,346 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Netflix faced a sharp move lower as investors weighed subscriber growth, content costs, and tougher competition. This...
The Ethereum Foundation slashes staff by 54 and trims annual spending, triggering a leaner path for ETH. Robert Kiyos...
Two Senate bills would let six-story apartment buildings use a single interior exit stair, a move that could lower co...
Regulators in Spain are sending a clear message: there will be no extensions for the EU crypto licensing deadline. Th...
After four days of tit-for-tat strikes, both sides signaled a pause in the Strait of Hormuz. Markets priced in a mana...
A government-backed AI initiative is building a data backbone to test nutrition-focused ideas in farming. Early pilot...
A potential Dow reshuffle could end Nike's long run in the index and swap it for a consumer-facing giant. This articl...
Retail investors often worry about when insiders will sell. This guide breaks down the precise timeline when insiders...
Microsoft's Xbox unit is cutting 3,200 jobs as part of a sweeping overhaul aimed at refocusing on the console and cor...
As AI tools ride into homebuilding, a new asset is emerging: institutional knowledge. Builders that centralize data a...
A new wall street warning market backdrop meets tax rules that lock RMDs to last year’s balance, potentially forcing ...